Literature DB >> 32527823

Aggregating data from COVID-19 trials.

Elizabeth L Ogburn1, Barbara E Bierer2,3, Ron Brookmeyer4, Christine Choirat5, Natalie E Dean6, Victor De Gruttola7, Susan S Ellenberg8, M Elizabeth Halloran9,10, Daniel F Hanley11, Joseph K Lee12, Rui Wang3,13, Daniel O Scharfstein14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32527823      PMCID： PMC8926083          DOI： 10.1126/science.abc8993

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  Against pandemic research exceptionalism.

Authors:  Alex John London; Jonathan Kimmelman
Journal:  Science       Date:  2020-04-23       Impact factor: 47.728

2.  Randomized Clinical Trials and COVID-19: Managing Expectations.

Authors:  Howard Bauchner; Phil B Fontanarosa
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

3.  Waste in covid-19 research.

Authors:  Paul P Glasziou; Sharon Sanders; Tammy Hoffmann
Journal:  BMJ       Date:  2020-05-12

4.  Responding to Covid-19 - A Once-in-a-Century Pandemic?

Authors:  Bill Gates
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

5.  Remdesivir for COVID-19: challenges of underpowered studies.

Authors:  John David Norrie
Journal:  Lancet       Date:  2020-04-29       Impact factor: 79.321

6.  COVID-19: time to plan for prompt universal access to diagnostics and treatments.

Authors:  Luca Li Bassi; Lenias Hwenda
Journal:  Lancet Glob Health       Date:  2020-04-16       Impact factor: 26.763

7.  Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Authors:  Natalie E Dean; Pierre-Stéphane Gsell; Ron Brookmeyer; Forrest W Crawford; Christl A Donnelly; Susan S Ellenberg; Thomas R Fleming; M Elizabeth Halloran; Peter Horby; Thomas Jaki; Philip R Krause; Ira M Longini; Sabue Mulangu; Jean-Jacques Muyembe-Tamfum; Martha C Nason; Peter G Smith; Rui Wang; Ana M Henao-Restrepo; Victor De Gruttola
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 176.079

Review 8.  Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?

Authors:  Hans-Georg Eichler; Marco Cavaleri; Harald Enzmann; Francesca Scotti; Bruno Sepodes; Fergus Sweeney; Spiros Vamvakas; Guido Rasi
Journal:  Clin Pharmacol Ther       Date:  2020-06-12       Impact factor: 6.903
  8 in total
  2 in total

1.  COVID-19 and Indigenous health in the Brazilian Amazon.

Authors:  Bruno Wichmann; Roberta Wichmann
Journal:  Econ Model       Date:  2022-07-18

Review 2.  How COVID-19 has fundamentally changed clinical research in global health.

Authors:  Jay J H Park; Robin Mogg; Gerald E Smith; Etheldreda Nakimuli-Mpungu; Fyezah Jehan; Craig R Rayner; Jeanine Condo; Eric H Decloedt; Jean B Nachega; Gilmar Reis; Edward J Mills
Journal:  Lancet Glob Health       Date:  2021-05       Impact factor: 38.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.